A reported case of modafinil overdose shows that extremely high doses can push the body into a state of intense stimulation, including insomnia, rapid heart rate, and abnormal movements, without necessarily leading to fatal outcomes. In this instance, a 5,000 [Read more…]
Source noteThis article summarizes experiences shared by people in online nootropic communities, including Reddit. These comments describe personal experimentation and should not be considered medical advice or clinical evidence. Piracetam has been part of the nootropics conversation for decades. Among [Read more…]
Piracetam has been studied since the early 1970s and has one of the stranger research profiles in pharmacology. It has been tested in stroke, dementia, dyslexia, cortical myoclonus, vertigo, and sickle cell anemia. It does not sedate. It does not [Read more…]
Modafinil has stronger regulatory backing and clearer evidence for improving wakefulness, while piracetam has a larger body of clinical research in cognitive impairment, a cleaner drug interaction profile, and a long record of tolerability, but no FDA approval in the [Read more…]
For narcolepsy, both modafinil and dextroamphetamine are approved to improve wakefulness. For ADHD, dextroamphetamine is approved, while modafinil is not approved for routine treatment in adults. The key differences involve stimulant intensity, abuse risk classification, and safety considerations, especially cardiovascular [Read more…]
Recent Comments